Radiaction Medical announced today that it raised $12.6 million in Series C2 funding and elected Christopher Barys to its board.
U.S. private equity fund InnovaHealth Partners led the Tel Aviv, Israel-based company’s round. Additional unnamed co-investors participated.
Radiaction develops a novel system designed to proactively block radiation from the source. It provides comprehensive, head-to-toe radiation protection for the entire interventional team. Meanwhile, it enables unencumbered patient care, access and service, according to a news release.
Backed by extensive lab testing and real-world validation, the company looks to expand its footprint in the U.S. It’s adding new sites to its user base, providing key support staff to ensure the success of each system installation. The company also looks to develop additional features and grow its clinical publication pipeline to support the technology’s performance.
“This current fin…